chr15-74720638-G-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001319217.2(CYP1A1):c.1390C>A(p.Arg464Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00702 in 1,614,134 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R464C) has been classified as Likely benign.
Frequency
Consequence
NM_001319217.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP1A1 | NM_001319217.2 | c.1390C>A | p.Arg464Ser | missense_variant | 7/7 | ENST00000379727.8 | |
CYP1A1 | NM_000499.5 | c.1390C>A | p.Arg464Ser | missense_variant | 7/7 | ||
CYP1A1 | NM_001319216.2 | c.1303C>A | p.Arg435Ser | missense_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP1A1 | ENST00000379727.8 | c.1390C>A | p.Arg464Ser | missense_variant | 7/7 | 1 | NM_001319217.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00454 AC: 690AN: 152148Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00425 AC: 1069AN: 251424Hom.: 3 AF XY: 0.00425 AC XY: 578AN XY: 135880
GnomAD4 exome AF: 0.00728 AC: 10638AN: 1461868Hom.: 50 Cov.: 31 AF XY: 0.00702 AC XY: 5104AN XY: 727236
GnomAD4 genome AF: 0.00453 AC: 690AN: 152266Hom.: 3 Cov.: 32 AF XY: 0.00403 AC XY: 300AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 07, 2018 | - - |
CYP1A1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at